A new publication provides manufacturers with recommendations to improve health equity for persons with disabilities and marginalized populations.
The World Health Organization will host a webinar on Oct 7 to launch its new publication “Rapid diagnostic test accessibility considerations for professional use and self-tests,” which provides concrete recommendations for manufacturers to advance health equity for persons with disabilities.
The publication addresses significant barriers that millions of people worldwide experience when obtaining and using rapid diagnostic tests, including those for HIV and SARS-CoV-2. These barriers include small or difficult-to-read fonts, confusing symbols, and physical difficulties with test kits, according to WHO.
While accessibility issues can affect anyone, they have a more serious impact on the health outcomes of millions of persons with disabilities, older adults, and other marginalized populations, WHO states.
Expert Panel Discussion
The online launch will feature experts from WHO, bilateral agencies, manufacturers, and civil society organizations discussing the importance of making diagnostics accessible for everyone. The webinar is scheduled for 2-3 pm CET (8-9 am EST) and will be conducted in English with captioning and interpretation in International Sign Language.
Rapid diagnostic tests have become widespread in laboratories, clinics, pharmacies, and homes globally over the past few decades. However, current accessibility challenges can prevent effective use among vulnerable populations.
WHO plans to publish additional information about the agenda and speakers on the event webpage. The publication’s recommendations could influence how manufacturers approach the design and packaging of rapid diagnostic tests across multiple disease areas.
ID 216497797 © Axel Bueckert | Dreamstime.com
